Integrating phase 2 into phase 3 based on an intermediate endpoint while accounting for a cure proportion-With an application to the design of a clinical trial in acute myeloid leukemia
| Image |  |
|---|---|
| Description | scientific article published on 28 August 2019 |
| Author/s |
author: Kaspar Rufibach |
| Publication date | August 28, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |